Nitric oxide dysregulates adipocytokine expression in 3T3-L1 adipocytes.

[1]  T. Yoshimoto,et al.  Chronic blockade of nitric oxide synthesis reduces adiposity and improves insulin resistance in high fat-induced obese mice. , 2007, Endocrinology.

[2]  L. Gleaves,et al.  Bone Marrow Plasminogen Activator Inhibitor-1 Influences the Development of Obesity* , 2006, Journal of Biological Chemistry.

[3]  S. Horiuchi,et al.  Nitric oxide-induced downregulation of leptin production by 3T3-L1 adipocytes. , 2006, Nitric oxide : biology and chemistry.

[4]  Y. Matsuzawa.  The metabolic syndrome and adipocytokines , 2006, FEBS letters.

[5]  Zheng‐gang Liu,et al.  JNK signaling pathway is a key modulator in cell death mediated by reactive oxygen and nitrogen species. , 2006, Free radical biology & medicine.

[6]  P Trayhurn,et al.  Signalling role of adipose tissue: adipokines and inflammation in obesity. , 2005, Biochemical Society transactions.

[7]  B. Dahiyat,et al.  JNK and Tumor Necrosis Factor-α Mediate Free Fatty Acid-induced Insulin Resistance in 3T3-L1 Adipocytes* , 2005, Journal of Biological Chemistry.

[8]  P. Trayhurn.  Endocrine and signalling role of adipose tissue: new perspectives on fat. , 2005, Acta physiologica Scandinavica.

[9]  K. Kunii,et al.  A role for iNOS in fasting hyperglycemia and impaired insulin signaling in the liver of obese diabetic mice. , 2005, Diabetes.

[10]  Morihiro Matsuda,et al.  Increased oxidative stress in obesity and its impact on metabolic syndrome. , 2004, The Journal of clinical investigation.

[11]  G. Frühbeck,et al.  Reduced adipose tissue mass and hypoleptinemia in iNOS deficient mice: effect of LPS on plasma leptin and adiponectin concentrations , 2004, FEBS letters.

[12]  Arya M. Sharma,et al.  Regulation of the nitric oxide system in human adipose tissue Published, JLR Papers in Press, July 1, 2004. DOI 10.1194/jlr.M300322-JLR200 , 2004, Journal of Lipid Research.

[13]  M. Matsuda,et al.  Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors. , 2003, Diabetes.

[14]  E. Clementi,et al.  Mitochondrial Biogenesis in Mammals: The Role of Endogenous Nitric Oxide , 2003, Science.

[15]  T. Mayumi,et al.  Nitration of PPARγ inhibits ligand‐dependent translocation into the nucleus in a macrophage‐like cell line, RAW 264 , 2002, FEBS letters.

[16]  P. Scherer,et al.  ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism , 2002, Trends in Endocrinology & Metabolism.

[17]  Zhong Yun,et al.  Inhibition of PPAR gamma 2 gene expression by the HIF-1-regulated gene DEC1/Stra13: a mechanism for regulation of adipogenesis by hypoxia. , 2002, Developmental cell.

[18]  R. Paschke,et al.  Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes. , 2002, Biochemical and biophysical research communications.

[19]  B. Morris,et al.  Activation of nuclear factor kappaB by nitric oxide in rat striatal neurones: differential inhibition of the p50 and p65 subunits by dexamethasone. , 2002, Journal of neurochemistry.

[20]  A. Marette,et al.  Targeted disruption of inducible nitric oxide synthase protects against obesity-linked insulin resistance in muscle , 2001, Nature Medicine.

[21]  R. Westrick,et al.  Plasminogen Activator Inhibitor-1 Regulates Tumor Growth and Angiogenesis* , 2001, The Journal of Biological Chemistry.

[22]  H. Forman,et al.  Redox signaling in macrophages. , 2001, Molecular aspects of medicine.

[23]  S. K. Kim,et al.  Increases in nitric oxide concentrations correlate strongly with body fat in obese humans. , 2001, Clinical chemistry.

[24]  H. Lijnen.  Elements of the Fibrinolytic System , 2001, Annals of the New York Academy of Sciences.

[25]  Paul Tempst,et al.  Protein S-nitrosylation: a physiological signal for neuronal nitric oxide , 2001, Nature Cell Biology.

[26]  S. Kihara,et al.  Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. , 2000, Blood.

[27]  B. Binder,et al.  Impact of adipose tissue on plasma plasminogen activator inhibitor-1 in dieting obese women. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[28]  R. Kamijo,et al.  Nitric oxide up-regulates the expression of intercellular adhesion molecule-1 on cancer cells. , 1999, Biochemical and biophysical research communications.

[29]  A. Rodríguez-Ariza,et al.  Rapid induction of NF-kappaB binding during liver cell isolation and culture: inhibition by L-NAME indicates a role for nitric oxide synthase. , 1999, Biochemical and biophysical research communications.

[30]  M. Gallina,et al.  Nitrite plasma levels in type 1 and 2 diabetics with and without complications. , 1998, Panminerva medica.

[31]  Philipp E. Scherer,et al.  The crystal structure of a complement-1q family protein suggests an evolutionary link to tumor necrosis factor , 1998, Current Biology.

[32]  J S Yudkin,et al.  Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1997 by The Endocrine Society Subcutaneous Adipose Tissue Releases Interleukin-6, But Not Tumor Necrosis Factor-�, in Vivo* , 2022 .

[33]  E. Choi,et al.  Nitric oxide modulates the c-Jun N-terminal kinase/stress-activated protein kinase activity through activating c-Jun N-terminal kinase kinase. , 1997, Biochemistry.

[34]  H. Lander,et al.  Differential Activation of Mitogen-activated Protein Kinases by Nitric Oxide-related Species* , 1996, The Journal of Biological Chemistry.

[35]  Carl Nathan,et al.  Nitric oxide synthases: Roles, tolls, and controls , 1994, Cell.

[36]  B. Binder,et al.  Matrix-bound plasminogen activator inhibitor type 1 inhibits the invasion of human monocytes into interstitial tissue. , 1990, Journal of immunology.

[37]  L. Ignarro,et al.  Nuclear Factor- (cid:1) B and Mitogen-activated Protein Kinases Mediate Nitric Oxide-enhanced Transcriptional Expression of Interferon- (cid:2) * , 2003 .